Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZT-1 Implant vs Donepezil in Moderate Alzheimer's Disease
NCT00423228Phase 2Completed
- Sponsor
- Debiopharm
- Start
- Feb 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of mimopezil in Alzheimer's disease (AD) (2 arms), sponsored by Debiopharm. Primary endpoint: Change in Mini-Mental State Examination Score at 25 weeks. Started Feb 2007; status: completed.
02
Drugs
mimopezil
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00423228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423228.